Data from Phase 2 open-label study of SAGE-217 in bipolar depression demonstrate rapid improvement compared to baseline; analysis of datasets …
Link to Full Article: Read Here
Jul 24, 2019 | News Stories
Data from Phase 2 open-label study of SAGE-217 in bipolar depression demonstrate rapid improvement compared to baseline; analysis of datasets …
Link to Full Article: Read Here